Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a Providence, Rhode Island-based biopharmaceutical company that went public through a merger with Pono Capital Two Corp., a blank-check company sponsored by Pono Capital LLC that completed its IPO in 2021. Operating in the life sciences and biotechnology sector, Ocean Biomedical focuses on developing treatments for cancer, pulmonary fibrosis, malaria, and infectious diseases, drawing on research originating from Brown University. The company filed a 10-Q with the SEC on October 17, 2022, under accession number 0001493152-22-028552, covering its quarterly financials as the de-SPAC transaction moved toward closing in early 2023. Visit SpacDesk and sign up for full data, filings history, and analytics on OCEA and hundreds of other SPAC transactions.